Stay in the know
Receive timely insights and briefings from HSF Kramer, tailored to keep you informed and ahead
We have established a reputation for advising clients on a variety of matters involving Switzerland over a number of years.
This has involved developing close relationships with leading Swiss counsel and working collaboratively with them. We combine our transactional, contentious, and regulatory experience with an appreciation of local practice and expectations to ensure our clients' goals are met.
Our Switzerland group comprises lawyers from across our international networks and from across a wide range of capabilities, enabling us to advise clients on the full spectrum of legal matters. These include, for example, large M&A matters, cross-border disputes and arbitrations, capital markets transactions, financings and transactions in the energy & mining, pharma & healthcare, consumer, real estate and infrastructure sectors.
Coca-Cola HBC, a Swiss-listed company listed on its acquisition of a 75% shareholding in Coca-Cola Beverages Africa Pty Ltd (“CCBA”) from The Coca-Cola Company and Gutsche Family Investments Pty Ltd for a combined purchase price of US$2.6 billion, implying an equity value for 100% of CCBA at US$3.4 billion
KKR in connection with the acquisition by Lonza Group AG (Swiss chemistry group) of the leading biopharmaceutical company Capsugel S.A. for an amount of USD 5.5 billion (including the refinancing of Capsugel's existing debt of around USD 2 billion)
Merrill Lynch Equities (Australia) Limited and Goldman Sachs Australia Pty Ltd as the Joint Lead Managers of CSL’s A$6.3 billion placement to institutional investors, to partially fund the A$16.4 billion acquisition of Vifor Pharma, a Switzerland-based global specialty pharmaceutical company with leadership in iron deficiency, nephrology & cardio-renal therapies
Swiss Re on its US$7.4 billion acquisition of GE Insurance Solutions, creating a new world market-leader in the field of reinsurance, using a transfer scheme
GS and UBS as financial advisors of Zurich Insurance on its takeover of Beazley plc
Dr Reddy’s Laboratories Limited on the acquisition of Haleon Plc’s nicotine replacement therapy business for £500m held by a Swiss entity (said to be one of the biggest outbound from India in this space)
Chambers Global 2026
Chambers Europe – Projects & Energy 2026
Chambers Europe Banking & Finance 2026
Partner, Paris
Senior Associate, London
Receive timely insights and briefings from HSF Kramer, tailored to keep you informed and ahead